Key result
Modified 2019 criteria lower estimated LVDD prevalence in cirrhosis to ~11% versus older guidelines.
Why the study?
To estimate the frequency of cirrhotic cardiomyopathy across all proposed diagnostic criteria, describe the spectrum of cardiac alterations, and investigate the role of stress in unmasking latent cases.
Does dobutamine stress testing and the use of different diagnostic criteria alter the estimated prevalence of cirrhotic cardiomyopathy in patients with cirrhosis?
Cross-Sectional (n=90)
No
Does dobutamine stress testing and the use of different diagnostic criteria alter the estimated prevalence of cirrhotic cardiomyopathy in patients with cirrhosis?
The prevalence of cirrhotic cardiomyopathy is highly dependent on the diagnostic criteria used, with the latest 2019 criteria yielding a much lower prevalence (11.1%) than older criteria, and dobutamine stress testing unmasks left systolic dysfunction in a small percentage of patients.
Criteria choice markedly affects prevalence estimates; leaves open which best predicts outcomes in prospective studies.
Background: We estimated the frequency of cirrhotic cardiomyopathy (CCM) using all of the proposed diagnostic criteria, to describe the whole spectrum of cardiac alterations, and to investigate the role of stress in unmasking latent cases of CCM. Methods: Ninety consecutive patients were recruited. CCM was evaluated using the Montreal, the American Society of Echocardiography 2009 criteria, and the 2019 modified criteria of the CCM consortium. A dobutamine stress test was also performed. Results: Left ventricular diastolic dysfunction (LVDD) was identified in 72 (80%), 36 (40%), and 10 (11.1%) patients based on the above criteria, respectively. None of the patients had right ventricular systolic dysfunction, either at rest or after stress. The dobutamine stress test revealed left systolic dysfunction in 4 (4.5%) patients. There was agreement among the 3 criteria that the presence of LVDD was not associated with the severity of liver disease, using Child-Pugh stage. However, patients with Child-B/C had longer QTc intervals (P=0.004), higher levels of brain natriuretic peptide (P=0.016), and greater echocardiographic E/e' ratio (P<0.001) and E/e'(s) (P=0.003), compared to Child-A patients, while a significant correlation was demonstrated between Child-Pugh score and E/e' (P<0.001), or E/e'(s) (P=0.002). Conclusions: The prevalence of LVDD seems to be lower than previously considered. Right ventricular function seems to remain unimpaired. A dobutamine stress uncovered only a small percentage of patients with left systolic dysfunction. Nevertheless, the aggravation of several sonographic variables during stress, particularly in Child-B/C patients, potentially indicates a higher risk for clinical heart failure during stressful invasive interventions.
No takes yet. Share an insight, caveat, or question.
Dimitrios S. Karagiannakis (2023) conducted a cross-sectional in Cirrhotic cardiomyopathy (n=90). Dobutamine stress test vs. Rest was evaluated on Prevalence of left ventricular diastolic dysfunction (LVDD) using 2019 modified criteria. The prevalence of left ventricular diastolic dysfunction in cirrhotic patients was 11.1% using the 2019 modified criteria, which is lower than the 80% and 40% estimated by older diagnostic criteria.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: